SUPERGEN INC
AI agent that generates video and image content and publishes to social media platforms
- Sector
- Software
- Headquarters
- DUBLIN, CA
- Latest Form D
- $3M, Nov 2009
- Total capital
- $3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3M
- 1 Form D · last Nov 2009
- 204 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 31 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Allan R. GoldbergDirectorNamed in SEC Form D filings
- Charles J. CasamentoDirectorNamed in SEC Form D filings
- James S.J. ManusoExecutive Officer, DirectorNamed in SEC Form D filings
- Michael D. MolkentinExecutive OfficerNamed in SEC Form D filings
- Michael D. YoungDirectorNamed in SEC Form D filings
- Mohammad D. AzabExecutive OfficerNamed in SEC Form D filings
Show all 8 people
- Thomas V. GirardiDirectorNamed in SEC Form D filings
- Walter J. LackDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 31- PendingCyclopentathiophene/cyclohexathiophene Dna Methyltransferase InhibitorsUSPTOApplication PCTUS2010000577
- PendingPyrrolopyrimidinyl Axl Kinase InhibitorsUSPTOApplication PCTUS2010000350
- PendingPYRIMIDINE-2,4-DIAMINE JAK2 Kinase Inhibiting Anti-inflammation UseUSPTOApplication PCTUS2009004330
Show all 31 patent records
- Cyclopentathiophene/cyclohexathiophene Dna Methyltransferase InhibitorsApplication PCTUS2010000577Pending
- Pyrrolopyrimidinyl Axl Kinase InhibitorsApplication PCTUS2010000350Pending
- PYRIMIDINE-2,4-DIAMINE JAK2 Kinase Inhibiting Anti-inflammation UseApplication PCTUS2009004330Pending
- Quinoline Derivatives For Modulating Dna MethylationApplication PCTUS2008079486Pending
- Axl Kinase InhibitorsApplication PCTUS2008060074Pending
- PYRIMIDINE-2,4-DIAMINE Derivatives And Their Use As JAK2 Kinase InhibitorsApplication PCTUS2008055452Pending
- IMIDAZO[1,2-B]PYRIDAZINE And PYRAZOLO[1,5-A]PYRIMIDINE Derivatives And Their Use As Protein Kinase InhibitorsApplication PCTUS2007083773Pending
- Protein Kinase InhibitorsApplication PCTUS2007083229Pending
- Quinoline Derivatives For Modulating Dna MethylationApplication PCTUS2007081321Pending
- Oligonucleotide Analogues Incorporating 5-AZA-CYTOSINE ThereinApplication PCTUS2006037313Pending
- Inhibitors Of Polo-like KINASE-1Application PCTUS2006019076Pending
- Protein Kinase InhibitorsApplication PCTUS2006016423Pending
- Azacytosine Analogs And DerivativesApplication PCTUS2006008588Pending
- Pharmaceutical Formulation Of DecitabineApplication PCTUS2005044676Pending
- Pharmaceutical Formulation Of Cytidine Analogs And DerivativesApplication PCTUS2005044379Pending
- Salts Of DecitabineApplication PCTUS2005034779Pending
- Salts Of 5-AZACYTIDINEApplication PCTUS2005033405Pending
- Compositions And Formulations Of Decitabine Polymorphs And Methods Of UseApplication PCTUS2005024676Pending
- Synthesis And Manufacture Of Pentostatin And Its Precursors, Analogs And DerivativesApplication PCTUS2004030203Pending
- Compositions And Methods For Treatment Of CancerApplication PCTUS2004022367Pending
- Composition And Method For Treating Neurological DisordersApplication PCTUS2004020600Pending
- Pharmaceutical Formulations Targeting Specific Regions Of The Gastrointestinal TractApplication PCTUS2003034781Pending
- Liquid Formulation Of Decitabine And Use Of The SameApplication PCTUS2003017293Pending
- Sequential Therapy Comprising A 20(S)-CAMPTOTHECIN And AnthracyclineApplication PCTUS2003016744Pending
- Compositions And Formulations Of 9-NITROCAMPTOTHECIN Polymorphs And Methods Of Use ThereofApplication PCTUS2003005118Pending
- Sequential Therapy Comprising A 20(S)-CAMPTOTHECIN Compound And A Pyrimidine Base AnalogApplication PCTUS2003003665Pending
- Method For Treating Diseases Associated With Abnormal Kinase ActivityApplication PCTUS2003003537Pending
- Method For Preparing And Using Polyoxyethylated Castor Oil In Pharmaceutical CompositionsApplication PCTUS2002038067Pending
- Composition And Method For Treating Graft-versus-host DiseaseApplication PCTUS2002032804Pending
- Compositions And Methods For Reestablishing Gene Transcription Through Inhibition Of Dna Methylation And Histone DeaetylaseApplication PCTUS2002012092Pending
- Restor Cancer-suppressing Functions To Neoplastic Cells Through Dna HypomethylationApplication PCTUS2002004135Pending
Related companies, and why
- ZeroNorthSimilar federal contract value in Software · null in contracts
- miPS, Inc.Similar federal contract value in Software · null in contracts
- Volcano Platforms, Inc.Similar federal contract value in Software · null in contracts
- Patsnap LtdSimilar federal contract value in Software · null in contracts
- Digital Harmonic LLCSimilar federal contract value in Software · null in contracts
- DECISION DETECTIVE CORPORATIONSimilar federal contract value in Software · null in contracts
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .